Johnson & Johnson’s (JNJ) single-dose COVID-19 vaccine was given an emergency use authorization (EAU) Saturday evening by U.S. Food and Drug Administration (FDA), making it the third vaccine available in the U.S.
The Vaccines and Related Biologics Products Advisory Committee (VRBPAC) voted unanimously Friday to recommend use of the vaccine on adults aged 18 and older, based on all the data submitted by the company, and the vaccine was endorsed by FDA staff earlier in the week.
J&J’s vaccine,…
Source link
